Discounted Cash Flow
Myriad Genetics Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $753.8m | $125.3m | $161.3m | 16.6% | $1.79 |
| 2017 | $771.4m (2.3%) | $21.8m (-82.6%) | $100.1m (-37.9%) | 2.8% (-83.0%) | $0.32 (-82.1%) |
| 2018 | $772.6m (0.2%) | $131.1m (501.4%) | $107.5m (7.4%) | 17.0% (500.4%) | $1.89 (490.6%) |
| 2019 | $851.1m (10.2%) | $4.6m (-96.5%) | $75.1m (-30.1%) | 0.5% (-96.8%) | $0.06 (-96.8%) |
| 2020 | $638.6m (-25.0%) | $-199.5m (-4437.0%) | $52.8m (-29.7%) | -31.2% (-5880.1%) | $-2.69 (-4583.3%) |
| 2021 | $690.6m (8.1%) | $-27.2m (86.4%) | $200.0k (-99.6%) | -3.9% (87.4%) | $-0.35 (87.0%) |
| 2022 | $678.4m (-1.8%) | $-112.0m (-311.8%) | $-151.6m (-75900.0%) | -16.5% (-319.2%) | $-1.39 (-297.1%) |
| 2023 | $753.2m (11.0%) | $-263.3m (-135.1%) | $-184.2m (-21.5%) | -35.0% (-111.7%) | $-3.18 (-128.8%) |
| 2024 | $837.6m (11.2%) | $-127.3m (51.7%) | $-38.4m (79.2%) | -15.2% (56.5%) | $-1.41 (55.7%) |
| 2025 | $824.5m (-1.6%) | $-365.9m (-187.4%) | $-25.6m (33.3%) | -44.4% (-192.0%) | $-3.95 (-180.1%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.